Stang, Alexander, Korn, Klaus, Wildner, Oliver et al. · Journal of clinical microbiology · 2005 · DOI
Researchers developed a new laboratory method called PAN-PCR that can identify viruses in patient samples even when standard tests fail to detect them. This technique works by finding viral genetic material protected inside virus particles and then copying and analyzing it. As a test case, they used this method on a mouth sample from a ME/CFS patient and successfully identified herpes simplex virus type 1, which had been missed by conventional testing.
This diagnostic method is relevant to ME/CFS research because some patients show evidence of viral involvement that conventional tests miss. The ability to identify unexpected or unknown viruses in clinical samples could help clarify the role of viral infections in ME/CFS pathogenesis and improve diagnostic accuracy for affected individuals.
This study does not prove that HSV-1 or other viruses cause ME/CFS, nor does it establish the prevalence of undetected viruses in ME/CFS populations. It is a methods paper demonstrating proof-of-concept; a single case identification does not establish causation or clinical significance. The study also does not determine whether detected viruses are latent, reactivated, or clinically relevant to disease pathology.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →